CHEMICAL SYNTHESIS OF RNA VIA NOVEL STRATEGY

Information

  • Research Project
  • 2024587
  • ApplicationId
    2024587
  • Core Project Number
    R43GM056044
  • Full Project Number
    1R43GM056044-01
  • Serial Number
    56044
  • FOA Number
  • Sub Project Id
  • Project Start Date
    6/1/1997 - 28 years ago
  • Project End Date
    11/30/1997 - 27 years ago
  • Program Officer Name
  • Budget Start Date
    6/1/1997 - 28 years ago
  • Budget End Date
    11/30/1997 - 27 years ago
  • Fiscal Year
    1997
  • Support Year
    1
  • Suffix
  • Award Notice Date
    5/28/1997 - 28 years ago
Organizations

CHEMICAL SYNTHESIS OF RNA VIA NOVEL STRATEGY

The growing interest in RNA structural components, ribozymes and other RNA functions has generated a need for reliable methods of synthesizing small RNA oligonucleotides (less than 50 nucleotides). Although RNA synthesis can be accomplished for some applications by knowledgeable specialists via either biochemical methods, e.g. transcription, or chemically, e.g. 5'-dimethoxytrityl-2'-silyl chemistry, there is a definite need for improved RNA synthesis methods. RNA synthesis would be considerably more powerful if readily accessible to biologists, who play central roles in driving advances in health-related research. Final processing of synthesized RNA must be done under mild, sterile conditions with minimal handling. Our final processing is accomplished under mild aqueous conditions, pH 3, 55 angstroms C for 10 minutes. The purpose of this study is twofold: (1) establish that this chemistry can be made commercially available, i.e. research and develop the novel protecting group so that they are amenable to large scale economical synthesis, (2) establish the general utility of this chemistry by synthesizing a variety of RNA oligonucleotides to be evaluated by several collaborators. Accomplishment of these goals would sastify the market need in the research community for ready access to RNA oligonucleotides.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R43
  • Administering IC
    GM
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    821
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    ZRG3
  • Study Section Name
  • Organization Name
    DHARMACON, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    LAFAYETTE
  • Organization State
    CO
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    800263375
  • Organization District
    UNITED STATES